Choose a language

New managers in Asia


Addcon announces new structure in Asia Pacific and the Middle East

During VIV Asia 2019, Bernd Kochannek, CEO and founder of Addcon has officially announced that Ryan Von de Leon will be the new regional manager for Asia Pacific. He will follow Dr. Anant Deshpande who was very successful in the role for the past few years. At the same time, Dr. Anant Deshpande will be the regional manager of the newly defined region “South Asia and Middle East”.

Ryan von de Leon has started with Addcon as Technical Sales Manager based in the Philippines. Over the years, his responsibility has grown to the East Asia region which covers the Philippines, Japan, Korea and Taiwan. From now on, he will work closely with Dr YK Chang, Dr. Christian Lückstädt and the team in Hongkong. One of the main tasks for the years to come will be to stabilise and grow the sales of the diformates range and also to launch the 3rd generation acidifiers throughout the region.

Dr Anant Deshpande will shift his focus and as such he will be more active in his home market in India and the neighbouring South Asian Countries. In addition he will build up a team for the region to ensure a similar dynamic growth like he had achieved in his former APAC region. Dr. Anant Deshpande is proud to announce that he has already managed to get Dr. Stevan Petrovic in his team to support the partners in the Middle East. In addition, Dr. Deshpande is looking for additional managers to secure the dynamic development in the region.

It has been agreed, that all distributors in the region will be serviced by the Addcon office in Hongkong and will be supplied from the existing production sites in Norway and Germany.

Over the past years, Addcon´s diformates product range has developed into the number one gut acidifier globally. Customers around the world trust the effectiveness of the double salts of formic acid as a replacement of antibiotic growth promoters. Last year, Addcon has launched a new range of “3rd generation acidifiers” which are capable to control both gram + and gram- bacteria and hence will help to reduce the use of antibiotics even further.

< back to list